Assenagon Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Assenagon Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,037,736	Closed	-$4.25M	–	1641
2022 Q1	$4.25M	Buy	1,037,736 +785,443	+311%	+$2.85M	0.01%	569
2021 Q4	$901K	Sell	252,293 -907,153	-78%	-$3.17M	﹤0.01%	1062
2021 Q3	$4.22M	Sell	1,159,446 -71,515	-6%	-$289K	0.01%	485
2021 Q2	$5.37M	Buy	1,230,961 +575,910	+88%	+$2.35M	0.02%	467
2021 Q1	$2.69M	Buy	655,051 +336,788	+106%	+$1.46M	0.01%	648
2020 Q4	$1.27M	Sell	318,263 -206,302	-39%	-$667K	0.01%	656
2020 Q3	$1.42M	Buy	524,565 +70,795	+16%	+$196K	0.01%	672
2020 Q2	$1.25M	Buy	453,770 +430,360	+1,838%	+$1.2M	0.01%	737
2020 Q1	$55K	Buy	+23,410	New	+$79.6K	﹤0.01%	745

Other funds holding ATRS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Assenagon Asset Management's ATRS Position: Q2 2022 in Review

Assenagon Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,037,736 shares — an estimated $4.25M sold.

Assenagon Asset Management first reported a position in ATRS in Q1 2020 and held it in 9 quarters. The position peaked at $5.37M in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Assenagon Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Assenagon Asset Management sold 1,037,736 Antares Pharma, Inc. shares in Q2 2022, an estimated $4.25M.
Assenagon Asset Management first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 9 quarters.
Assenagon Asset Management's Antares Pharma, Inc. position peaked at $5.37M in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Assenagon Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.